Status:
COMPLETED
Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
6-15 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare Symbicort with budesonide alone for the treatment of asthma in children aged 6 to 15 years
Eligibility Criteria
Inclusion
- At least 6 and maximally 15 years of age
- Diagnosis of asthma and baseline lung function tests as determined by the protocol
- Has required and received treatment with inhaled corticosteroids within the timeframe and doses specified in the protocol
Exclusion
- Severe asthma
- Has required treatment with any non-inhaled corticosteroids within previous 4 weeks, has sensitivity to drugs specified in the protocol or requires treatment with beta-blockers
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2004
Estimated Enrollment :
540 Patients enrolled
Trial Details
Trial ID
NCT00646321
Start Date
April 1 2003
End Date
August 1 2004
Last Update
January 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.